Gaucher disease, a common lysosomal storage disorder, remains underdiagnosed due to symptoms mimicking anemia and liver conditions. Caused by glucocerebrosidase deficiency, it leads to lipid buildup in organs. Early diagnosis is crucial, as treatments like enzyme replacement therapy and substrate reduction therapy can improve outcomes, prevent complications, and enhance quality of life.